UBS Upgrades Illumina to Buy, Raises Price Target to $260
UBS analyst Doug Schenkel upgrades Illumina (NASDAQ:ILMN) from Neutral to Buy and raises the price target from $135 to $260.
A big investment bank thinks Illumina is now a good company to own and believes it could be worth much more money soon. When experts change their minds like this, it's worth paying attention to what they see that they didn't notice before.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.